Pfizer and BioNTech report data from an interim efficacy analysis showing that their Covid-19 vaccine is more than 90% effective in preventing the vir...
FDAs Peripheral and Central Nervous System Drugs Advisory Committee votes not to recommend approval of Biogens Alzheimers drug aducanumab.
President-elect Joe Bidens transition team announces the formation of the Transition Covid-19 Advisory Board, which is co-chaired by former FDA commis...
CDER posts a report on Global Participation in Clinical Trials: 2015-2019 that summarizes the Centers Drug Trials Snapshot program by illustrating the...
Federal Register notice: FDA releases a final guidance describing insanitary conditions at drug compounding facilities.
FDA posts a final guidance on Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017.
FDA issues a final guidance discussing when a microneedling product is a device for regulatory purposes.